Pharmacology

CHADS2, anticoagulation treatment, stroke, atrial fibrillation, Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trialCHADS2, anticoagulation treatment, stroke, atrial fibrillation, Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial

CHADS2, anticoagulation treatment, stroke, atrial fibrillation, Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trialCHADS2, anticoagulation treatment, stroke, atrial fibrillation, Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial

CHADS2, anticoagulation treatment, stroke, atrial fibrillation, Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trialCHADS2, anticoagulation treatment, stroke, atrial fibrillation, Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) trial

H pylori, atherosclerosisH pylori, atherosclerosis

H pylori, atherosclerosisH pylori, atherosclerosis

H pylori, atherosclerosisH pylori, atherosclerosis

esomeprazole, famotidine, gastrointestinal, gastrointestinal bleedingesomeprazole, famotidine, gastrointestinal, gastrointestinal bleeding

esomeprazole, famotidine, gastrointestinal, gastrointestinal bleedingesomeprazole, famotidine, gastrointestinal, gastrointestinal bleeding

esomeprazole, famotidine, gastrointestinal, gastrointestinal bleedingesomeprazole, famotidine, gastrointestinal, gastrointestinal bleeding

Alzheimer DiseaseAlzheimer Disease

Alzheimer DiseaseAlzheimer Disease

Alzheimer DiseaseAlzheimer Disease

diabetes, ophthalmology, vision, glucosediabetes, ophthalmology, vision, glucose

diabetes, ophthalmology, vision, glucosediabetes, ophthalmology, vision, glucose

diabetes, ophthalmology, vision, glucosediabetes, ophthalmology, vision, glucose

cholesterol, LDL-C, low-density lipoproteinscholesterol, LDL-C, low-density lipoproteins

cholesterol, LDL-C, low-density lipoproteinscholesterol, LDL-C, low-density lipoproteins

cholesterol, LDL-C, low-density lipoproteinscholesterol, LDL-C, low-density lipoproteins

Valproic acid, blood, bipolarValproic acid, blood, bipolar

Valproic acid, blood, bipolarValproic acid, blood, bipolar

Valproic acid, blood, bipolarValproic acid, blood, bipolar

hypoglycemia, in-hospital mortality, diabeteshypoglycemia, in-hospital mortality, diabetes

hypoglycemia, in-hospital mortality, diabeteshypoglycemia, in-hospital mortality, diabetes

hypoglycemia, in-hospital mortality, diabeteshypoglycemia, in-hospital mortality, diabetes

hyperkalemia, spirinolactone, trimethoprim-sulfamethoxazolehyperkalemia, spirinolactone, trimethoprim-sulfamethoxazole

hyperkalemia, spirinolactone, trimethoprim-sulfamethoxazolehyperkalemia, spirinolactone, trimethoprim-sulfamethoxazole

hyperkalemia, spirinolactone, trimethoprim-sulfamethoxazolehyperkalemia, spirinolactone, trimethoprim-sulfamethoxazole

medication problems, undertreatment, underdosing, black patients, nonadherence, suboptimal drug usemedication problems, undertreatment, underdosing, black patients, nonadherence, suboptimal drug use

medication problems, undertreatment, underdosing, black patients, nonadherence, suboptimal drug usemedication problems, undertreatment, underdosing, black patients, nonadherence, suboptimal drug use

medication problems, undertreatment, underdosing, black patients, nonadherence, suboptimal drug usemedication problems, undertreatment, underdosing, black patients, nonadherence, suboptimal drug use